Cross-over comparative study of the skin microbiome for atopic dermatitis using soap SO-145

未提供0 个研究点目标入组 44 人开始时间: 待定最近更新: 2024年8月16日

适应症

试验速览

暂无简介。

•Among patients with mild atopic dermatitis
•Patients who have received sufficient
•explanation before participating in this study, and
•who have obtained written consent at the
•discretion of the patient or their guardian with sufficient understanding.
•Staphylococcus epidermidis and Staphylococcus aureus carriers in patients with mild or mild eruption who have been diagnosed with atopic dermatitis based on the definition and diagnostic
•criteria for atopic dermatitis.

•Adrenal steroids Taking steroids, intensifying the platinum immunomodulatory drug
•Basic sterilization Illness Slightly preventive bactericidal drug is taken internally
•Patients who are recommended to use topical steroids on the face
•Patients who originally use FSDG for soap
•Patients, researchers, research coordinators

Percentage of Staphylococcus epidermidis 12 weeks after the start of use

Percentage of Staphylococcus aureus(4 and 12 weeks after the start of use and 4 weeks after the end of use)
Percentage of Staphylococcus aureus, TEWL, keratin water content, pH(4 and 12 weeks after the start of use and 4 weeks after the end of use)

发起方

未提供